Cardiac troponin T as an indicator of reduced left ventricular contractility in experimental anthracycline-induced cardiomyopathy

Cancer Chemotherapy and Pharmacology

Volumn 52, Issue 5, 2003, Pages 431-434

  Šimůnek, Tomáš ^a   Klimtová, Ivona ^a   Adamcová, Michaela ^b   Geršl, Vladimir ^b   Hrdina, Radomír ^a   Štěrba, Martin ^b   Kaplanová, Jana ^b   Mazurová, Yvona ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cardiac troponin T; Cardiotoxicity; Daunorubicin; Left ventricular contractility

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CHINCHILLA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; FUNCTIONAL ASSESSMENT; HEART FUNCTION TEST; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; IMMUNOASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CHINCHILLA; DAUNORUBICIN; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RABBITS; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0242360809     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0675-z     Document Type: Article

References (16)

1. Adamcova M, Gersl V, Hrdina R, Melka M, Mazurova Y, Vavrova J, Palicka V, Kokstein Z (1999) Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. J Cancer Res Clin Oncol 125:268
2. Bertinchant JP, Polge A, Juan JM, Oliva-Lauraire MC, Giuliani I, Marty-Double C, Burdy JY, Fabbro-Peray P, Laprade M, Bali JP, Granier C, de la Coussaye JE, Dauzat M (2003) Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy in rats, and their relationship with echocardiographic and histological findings. Clin Chim Acta 329:39
3. Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamatia G, Cinieri S, Martinelli G, Cipolla CM, Fiorentini C (2000) Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36:517
4. Cassidy SC, Chan DP, Rowland DG, Allen HD (1998) Effects of doxorubicin on diastolic function, contractile reserve, and ventricular-vascular coupling in piglets. Pediatr Cardiol 19:450
5. Della Torre P, Podesta A, Imondi AR, Moneta D, Sammartini U, Arrigoni C, Terron A, Brughera M (2001) PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential. Cancer Chemother Pharmacol 47:355
6. Herman EH, Ferrans VJ (1998) Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. Semin Oncol 25 [4 Suppl 10]:15
7. Herman EH, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, Takeda K, Ferrans VJ (1998) Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res 58:195
8. Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, Yu ZX, Ferrans VJ (1999) Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17:2237
9. Herman EH, Zhang J, Rifai N, Lipshultz SE, Hasinoff BB, Chadwick DP, Knapton A, Chai J, Ferrans VJ (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin-and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 48:297
10. Hrdina R, Gersl V, Klimtova I, Simunek T, Machackova J, Adamcova M (2000) Anthracycline-induced cardiotoxicity. Acta Medica (Hradec Kralove) 43:75
11. Joint European Society of Cardiology/American College of Cardiology Committee (2000) Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959
12. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KH, Kubler W (1991) Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902
13. La Vecchia L, Mezzena G, Ometto R, Finocchi G, Bedogni F, Soffiati G, Vincenzi M (1997) Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 80:88
14. Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME (1997) Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 96:2641
15. Singal PK, Iliskovic N, Li T, Kumar D (1998) Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J 11:931
16. van der Laarse A (2002) Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure. Cardiovasc Res 56:8